Aminocaproic acid
آمینوکاپروئیک اسید
🩸 Blood And Blood Forming OrgansAntifibrinolytic
Market / country: 🇺🇸 USA
Amicar (US)
🧮 Dose calculator
Bleeding from excessive fibrinolysis · Regimen source: FDA Aminocaproic acid · Dosage and Administration
- • The calculator gives the hourly 1 g dose; the first hour is 5 g. Continue until bleeding is controlled. Only with confirmed primary fibrinolysis, not DIC. FDA Aminocaproic acid · Dosage and AdministrationFDA Aminocaproic acid · Contraindications
Enter age (weight is optional for this regimen).
🛡️ Safety & information
Contraindications
- ⛔ Evidence of an active intravascular clotting process (DIC). FDA Aminocaproic acid · Contraindications
Warnings
- • Upper urinary tract bleeding: risk of obstructing clots; myopathy and rhabdomyolysis with prolonged use. FDA Aminocaproic acid · Warnings
Formulations
- 500 mg tablet (scored) — tablet 🇺🇸 USA FDA Aminocaproic acid · How Supplied
- 1000 mg tablet (scored) — tablet 🇺🇸 USA FDA Aminocaproic acid · How Supplied
👥 Special populations
- 🤰 PregnancyUse with caution
Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Aminocaproic acid · Pregnancy
“Animal reproduction studies have not been conducted with aminocaproic acid tablets.”
- 🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Aminocaproic acid · Nursing Mothers
“Because many drugs are excreted in human milk, caution should be exercised when aminocaproic acid tablets are administered to a nursing woman.”
- 👶 ChildrenSafety not established
Label: safety and effectiveness in children have not been established. FDA Aminocaproic acid · Pediatric Use
“Safety and effectiveness in pediatric patients have not been established.”
- 👴 Older adultsNo data
The source for this drug has no section for this group.
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)ANDA213944
- DailyMed (FDA label)FDA Aminocaproic acid
- MedlinePlus (NIH)Aminocaproic AcidAminocaproic Acid Injection
- WHO ATC/DDDB02AA01
- Darooyab (Iran)Aminocaproic-Acid
🇮🇷 Registered in Iran Darooyab · G-1377/Aminocaproic-Acid
Dosage forms with Iranian generic codes, per Darooyab.
- 02077 · AMINOCAPROIC ACID 250MG/ML AMP · آمپول آمینوکاپروئیک اسید ۲۵۰ میلیگرم / میلیلیتر
- 02078 · AMINOCAPROIC ACID 4G/10ML AMP · آمپول آمینوکاپروئیک اسید ۴ گرم / ۱۰ میلیلیتر
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Aminocaproic acid · How SuppliedFDA Aminocaproic acid · Dosage and AdministrationFDA Aminocaproic acid · ContraindicationsFDA Aminocaproic acid · WarningsFDA Aminocaproic acid · SPL approval / marketing categoryFDA Aminocaproic acid · PregnancyFDA Aminocaproic acid · Nursing MothersFDA Aminocaproic acid · Pediatric Use
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-1377/Aminocaproic-Acid
- Clinical review⚠ Unverified